Blake Long, Chief Medical Officer, and Hannah Mamuszka, Founder & CEO, Alva10 Over the last few months, the Food and Drug Administration’s accelerated approval of oncology drugs has come under increased scrutiny. Introduced in response to the HIV epidemic in 1992, accelerated approval is one of several regulatory pathways employed…